Perspective on Circulating Tumor Cell Clusters: Why It Takes a Village to Metastasize

Mario Giuliano(Regione Campania), Meghana V. Trivedi(University of Houston), Grazia Arpino(University of Naples Federico II), Xiang H.-F. Zhang(Baylor College of Medicine), Sabino De Placido, Anum Shaikh(University of Houston), Rachel Schiff(Baylor College of Medicine), Hin Ching Lo(Baylor College of Medicine), Massimo Cristofanilli(Breast Cancer Care)
Cancer Research
February 2, 2018
10.1158/0008-5472.can-17-2748
Cited by 221

Related Papers

Fulvestrant plus palbociclib versus fulvestrant plus placebo for treatment of hormone-receptor-positive, HER2-negative metastatic breast cancer that progressed on previous endocrine therapy (PALOMA-3): final analysis of the multicentre, double-blind, phase 3 randomised controlled trial
|The Lancet Oncology|2016|1.8k
Palbociclib in Hormone-Receptor–Positive Advanced Breast Cancer
|New England Journal of Medicine|2015|1.6k
Overall Survival with Palbociclib and Fulvestrant in Advanced Breast Cancer
|New England Journal of Medicine|2018|1.3k
Serpins Promote Cancer Cell Survival and Vascular Co-Option in Brain Metastasis
|Cell|2014|882
Mutual regulation of tumour vessel normalization and immunostimulatory reprogramming
|Nature|2017|853